Incyte to Report Third Quarter 2009 Financial Results and Provide Update on Drug Discovery & Development Programs on November 5

• Press Release
• Source: Incyte Corporation
• On 4:10 pm EDT, Tuesday October 20, 2009

WILMINGTON, Del.--(BUSINESS WIRE)--Incyte Corporation (Nasdaq:INCY - News) announced today that it has scheduled its third quarter 2009 financial results conference call for 8:30 a.m. ET on Thursday, November 5, 2009. The schedules for the press release and conference call are as follows:

Related Quotes

Symbol	Price	Change
INCY	8.39	-0.07

{"s" : "incy","k" : "c10,l10,p20,t10","o" : "","j" : ""}

If you are unable to participate, a replay of the conference call will be available for thirty days. The replay dial-in number for the U.S. is 877-660-6853 and dial-in number for international callers is 201-612-7415. To access the replay you will need the conference account number 278 and the ID number 335579.

The conference call will also be webcast live on CCBN and can be accessed at www.incyte.com under Investor Relations, Events and Webcasts.

About Incyte

Incyte Corporation is a Wilmington, Delaware-based drug discovery and development company focused on developing proprietary small molecule drugs for oncology, inflammation and diabetes. Incyte’s most advanced compound, INCB18424, is in Phase III development for myelofibrosis. For additional information on Incyte, visit the Company's web site at www.incyte.com.

Incyte
Pamela M. Murphy
Vice President, Investor Relations & Corporate Communications
302-498-6944